ASN's Mission

ASN leads the fight to prevent, treat, and cure kidney diseases throughout the world by educating health professionals and scientists, advancing research and innovation, communicating new knowledge, and advocating for the highest quality care for patients.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005


The Latest on Twitter

About ASN

Mark D. Okusa, MD, FASN, BRCU Faculty

ASN Biography

Mark D. Okusa, MD, FASN, is a graduate of George Washington University and Medical College of Virginia. He pursued residency training at the Medical College of Virginia/Virginia Commonwealth University and nephrology training at Yale University. He has been a faculty member at the University of Virginia School of Medicine and is currently the John C. Buchanan Distinguished Professor of Medicine, Director of the Center for Immunity, Inflammation, and Regenerative Medicine, and Chief of Nephrology. He has contributed to the development of a balanced research, educational and clinical program at the University of Virginia while promoting the career development of junior faculty. Through his contributions as principal investigator on an NIH T32 he has fostered the development of physician scientists and research scientists. His research involves the role of inflammation and immune cells in initiating and maintaining acute kidney injury. Through continuous funding from the National Institutes of Health since 1999, he has focused research on preclinical studies using adenosine 2a receptor and sphingosine 1-phosphate receptor agonists in both acute kidney injury using genetic models of kidney injury.

He serves as a member of the editorial boards for the Journal of the American Society of Nephrology, American Journal of Physiology, Kidney International, and the American Journal of Nephrology. He was the associate editor of Kidney International and Nephron. He was the past Chair of the Acute Kidney Injury Advisory Committee of the American Society of Nephrology and member of the Acute Kidney Injury Network and ASN Grants Committee. He served on the ASN Program Committee in 2007, 2010 and was Chair of the Program Committee in 2011. He was a regular member of the NIH Pathobiology of Kidney Disease Study Section and currently serves as a standing member of the NIDDK-KUH Fellowship Review Panel. He has been listed in Castle Connally’s America’s Top Doctors (2001-2014), member of the American Clinical and Climatological Association and elected Councilor to the American Society of Nephrology in 2012.